Rakovina Therapeutics Inc

Research Rakovina Therapeutics Inc (RKV) on Bullrun: market cap CAD 3.42M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerRKV
• ExchangeV
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyCAD
• Market capCAD 3.42M
• Financial periodQ3 2025
• Net income-CAD 1.78M
• Free cash flow-CAD 1.04M

Valuation Snapshot

latest market cap is CAD 3.42M.

About Rakovina Therapeutics Inc

Rakovina Therapeutics Inc., a biopharmaceutical research company, engages in the research and development of cancer treatments that target DNA-damage response systems. It develops kt-2000 series, which are patented class of oral, small molecule PARP inhibitors with established in vitro and in vivo proof of concept; kt-3000 series drug candidates, which are bi-functional targeted small molecules designed to inhibit both PARP and histone deacetylase;

Frequently asked questions

What is Rakovina Therapeutics Inc's market cap?

Rakovina Therapeutics Inc's market capitalization is CAD 3.42M.

What does Rakovina Therapeutics Inc do?

Rakovina Therapeutics Inc., a biopharmaceutical research company, engages in the research and development of cancer treatments that target DNA-damage response systems.